Model Shows: Investing in Hep B Saves Money, Lives

In November 2024, the Center for Disease Analysis Foundation released Public Health Impact of a Population-Based Approach to Hepatitis B Prevention and Treatment in Hawaiʻi, in partnership with the Hawaiʻi Department of Health.

Highlights from hep b modeling report

The report showed that scaling up testing and treatment will reduce health and economic impacts of hep B on Hawaiʻi, with the following highlights:

• More hep B testing and treatment would prevent liver cancer and save lives.

• Scaling up hep B testing and treatment saves long-term healthcare costs;

• A return on investment is estimated at 120% ($1.20 gained for every $1.00 spent);

For a short summary of the findings, see the handout from Hep Free Hawaiʻi.